Literature DB >> 26858153

miR-373 Inhibits Glioma Cell U251 Migration and Invasion by Down-Regulating CD44 and TGFBR2.

Furong Wei1, Qianrong Wang2, Qinghong Su1, Haiyan Huang1, Junwen Luan1, Xiaoqun Xu3, Junfu Wang4.   

Abstract

Glioblastoma multiforme (GBM) is the most malignant glioma, unveiling the underlying mechanisms of its aggressiveness could promote the discovery of potential targets for effective treatment. MicroRNAs (miRNAs) are important participants in both development and disease, its involvement in cancers has long been recognized. In this study, we investigated the role of miRNA-373 (miR-373) in GBM cell line U251, demonstrated that although miR-373 does not affect cell growth of U251, it inhibits migration and invasion of U251. Forced expression of miR-373 down-regulates the expressions CD44 and TGFBR2, while knockdown of CD44 and TGFBR2 presents the similar phenotype as miR-373 overexpression, suggesting that CD44 and TGFBR2 are functional targets of miR-373, down-regulation of CD44 and TGFBR2 by miR-373 are partly responsible for the migration, and invasion suppressive role of miR-373 in U251.

Entities:  

Keywords:  CD44; Glioma; Invasion; Migration; TGFBR2; miRNA-373

Mesh:

Substances:

Year:  2016        PMID: 26858153     DOI: 10.1007/s10571-016-0338-3

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  44 in total

1.  A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Authors:  P Mathijs Voorhoeve; Carlos le Sage; Mariette Schrier; Ad J M Gillis; Hans Stoop; Remco Nagel; Ying-Poi Liu; Josyanne van Duijse; Jarno Drost; Alexander Griekspoor; Eitan Zlotorynski; Norikazu Yabuta; Gabriella De Vita; Hiroshi Nojima; Leendert H J Looijenga; Reuven Agami
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

2.  High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.

Authors:  Alejandra Bruna; Rachel S Darken; Federico Rojo; Alberto Ocaña; Silvia Peñuelas; Alexandra Arias; Raquel Paris; Avelina Tortosa; Jaume Mora; Jose Baselga; Joan Seoane
Journal:  Cancer Cell       Date:  2007-02       Impact factor: 31.743

3.  Upregulation of miR-107 Inhibits Glioma Angiogenesis and VEGF Expression.

Authors:  Lei Chen; Zong-yang Li; Sui-yi Xu; Xie-jun Zhang; Yuan Zhang; Kun Luo; Wei-ping Li
Journal:  Cell Mol Neurobiol       Date:  2015-06-18       Impact factor: 5.046

4.  MiR-218 Inhibited Growth and Metabolism of Human Glioblastoma Cells by Directly Targeting E2F2.

Authors:  Yaxuan Zhang; Dongfeng Han; Wenjin Wei; Wenping Cao; Rui Zhang; Qingsheng Dong; Junxia Zhang; Yingyi Wang; Ning Liu
Journal:  Cell Mol Neurobiol       Date:  2015-05-27       Impact factor: 5.046

5.  Identification and functional characterization of microRNAs involved in the malignant progression of gliomas.

Authors:  Bastian Malzkorn; Marietta Wolter; Franziska Liesenberg; Michael Grzendowski; Kai Stühler; Helmut E Meyer; Guido Reifenberger
Journal:  Brain Pathol       Date:  2009-09-19       Impact factor: 6.508

6.  Micro RNA-373 is down-regulated in pancreatic cancer and inhibits cancer cell invasion.

Authors:  Kohei Nakata; Kenoki Ohuchida; Kazuhiro Mizumoto; Shinichi Aishima; Yoshinao Oda; Eishi Nagai; Masao Tanaka
Journal:  Ann Surg Oncol       Date:  2014-04-19       Impact factor: 5.344

7.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

Review 8.  Diverse functions of miR-373 in cancer.

Authors:  Furong Wei; Chuanhua Cao; Xiaoqun Xu; Junfu Wang
Journal:  J Transl Med       Date:  2015-05-20       Impact factor: 5.531

9.  miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells.

Authors:  Xue-Tao Li; Hang-Zhou Wang; Zhi-Wu Wu; Tian-Quan Yang; Zhao-Hui Zhao; Gui-Lin Chen; Xue-Shun Xie; Bin Li; Yong-Xin Wei; Yu-Lun Huang; You-Xin Zhou; Zi-Wei Du
Journal:  Cell Mol Neurobiol       Date:  2015-02-08       Impact factor: 5.046

Review 10.  MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients.

Authors:  M Pichler; G A Calin
Journal:  Br J Cancer       Date:  2015-07-09       Impact factor: 7.640

View more
  17 in total

1.  Whether CD44 is an applicable marker for glioma stem cells.

Authors:  Hsiao-Han Wang; Chen-Chieh Liao; Nan-Haw Chow; Lynn Ling-Huei Huang; Jih-Ing Chuang; Kuo-Chen Wei; Jyh-Wei Shin
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

2.  The Potential Contribution of microRNAs in Anti-cancer Effects of Aurora Kinase Inhibitor (AZD1152-HQPA).

Authors:  Ali Zekri; Yashar Mesbahi; Elham Boustanipour; Zahra Sadr; Seyed H Ghaffari
Journal:  J Mol Neurosci       Date:  2018-07-26       Impact factor: 3.444

3.  MicroRNA-373 promotes cell migration via targeting salt-inducible kinase 1 expression in melanoma.

Authors:  Xinping Bai; Ming Yang; Yi Xu
Journal:  Exp Ther Med       Date:  2018-09-21       Impact factor: 2.447

4.  Photoacoustic-Guided Surgery with Indocyanine Green-Coated Superparamagnetic Iron Oxide Nanoparticle Clusters.

Authors:  Jayesh P Thawani; Ahmad Amirshaghaghi; Lesan Yan; Joel M Stein; Jessica Liu; Andrew Tsourkas
Journal:  Small       Date:  2017-07-27       Impact factor: 13.281

5.  MicroRNA-98 Attenuates Cell Migration and Invasion in Glioma by Directly Targeting Pre-B Cell Leukemia Homeobox 3.

Authors:  Xiupeng Xu; Zhongyuan Bao; Yinlong Liu; Jing Ji; Ning Liu
Journal:  Cell Mol Neurobiol       Date:  2017-01-25       Impact factor: 5.046

Review 6.  Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents.

Authors:  Xiaohuan Xia; Yi Wang; Yunlong Huang; Han Zhang; Hongfang Lu; Jialin C Zheng
Journal:  Prog Neurobiol       Date:  2019-09-19       Impact factor: 11.685

Review 7.  Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma.

Authors:  Wanli Yu; Sai Liang; Chunzhi Zhang
Journal:  Neuromolecular Med       Date:  2018-09-04       Impact factor: 3.843

8.  Expression and role of microRNA-1271 in the pathogenesis of osteosarcoma.

Authors:  Gongbiao Lu; Lin Du; Yi Guo; Baohua Xing; Jishou Lu; Yanchun Wei
Journal:  Exp Ther Med       Date:  2017-12-15       Impact factor: 2.447

9.  LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis.

Authors:  Hongchao Xu; Beilin Zhang; Yinggui Yang; Zihuang Li; Pan Zhao; Weiqing Wu; Huirong Zhang; Jie Mao
Journal:  J Cell Mol Med       Date:  2020-04-22       Impact factor: 5.310

Review 10.  Potential Epigenetic-Based Therapeutic Targets for Glioma.

Authors:  Lanlan Zang; Shukkoor Muhammed Kondengaden; Fengyuan Che; Lijuan Wang; Xueyuan Heng
Journal:  Front Mol Neurosci       Date:  2018-11-15       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.